BioPharma Companies
Scientists within Biotechnology and Pharmaceutical companies have the
dual role of advancing mainstream core projects that are central to
the company’s business as well as developing new projects that will
feed into the product pipeline. At certain key points in your
company’s lifecycle, core activities naturally demand maximum input
from your internal scientists. This process is detrimental to the
progress of early stage projects, as they become relegated to ‘the
back burner’. This gives your competitors the edge.
Oxford BioPharma is well placed to help your internal
scientists develop intellectual property rights from early stage
projects that lie outwith the core activities of the company. Our
consultancy services are designed to keep abreast of advances in
subject areas relevant to those projects thus allowing your scientists
to concentrate their full attention on core activities sure in the
knowledge that their ‘upstream’ interests are being cared for.
To find out more about how we can help you,
contact us here |
|
|